≡

Checkpoint Kinase 1 (CHEK1)

[Edit]

CHK1; Cell cycle checkpoint kinase; Serine/threonine-protein kinase Chk1

Checkpoint Kinase 1 (CHEK1)
CCC L334
HGNC 1925
MGI 1202065
PubMed 23844225
RGD 620545
UniProt O14757
Wiki CHEK1
Chk1 is a kinase that phosphorylates cdc25, an important phosphatase in cell cycle control, particularly for entry into mitosis. Cdc25, when phosphorylated on serine 216 by chk1 becomes bound by an adaptor protein in the cytoplasm. Therefore it is inhibited from removing the inhibiting phosphate from MPF (mitotic/maturation promoting factor) added by Wee1. Consequently, a cell is prevented from entering mitosis.CHK1 is expressed ubiquitously as an approximately 2.4-kb mRNA, with the most abundant expression in thymus, testis, small intestine, and colon. Antibodies against CHK1 recognized a 54-kD protein on immunoblots of mammalian cell extracts. However, the protein had altered mobility when isolated from cells treated with ionizing radiation (IR), indicating that CHK1 is modified in response to DNA damage.

Organism species: Homo sapiens (Human)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins n/a Recombinant Checkpoint Kinase 1 (CHEK1) Recombinant Protein Customized Service Offer
Antibodies PAL334Hu01 Polyclonal Antibody to Checkpoint Kinase 1 (CHEK1) WB; IHC; ICC; IP.
Assay Kits n/a CLIA Kit for Checkpoint Kinase 1 (CHEK1) CLIA Kit Customized Service Offer
n/a ELISA Kit for Checkpoint Kinase 1 (CHEK1) ELISA Kit Customized Service Offer

Organism species: Mus musculus (Mouse)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins RPL334Mu01 Recombinant Checkpoint Kinase 1 (CHEK1) Positive Control; Immunogen; SDS-PAGE; WB.
RPL334Mu02 Recombinant Checkpoint Kinase 1 (CHEK1) Positive Control; Immunogen; SDS-PAGE; WB.
Antibodies PAL334Mu01 Polyclonal Antibody to Checkpoint Kinase 1 (CHEK1) WB; IHC; ICC; IP.
PAL334Mu02 Polyclonal Antibody to Checkpoint Kinase 1 (CHEK1) WB; IHC; ICC; IP.
Assay Kits SEL334Mu ELISA Kit for Checkpoint Kinase 1 (CHEK1) Enzyme-linked immunosorbent assay for Antigen Detection.

Organism species: Rattus norvegicus (Rat)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins n/a Recombinant Checkpoint Kinase 1 (CHEK1) Recombinant Protein Customized Service Offer
Antibodies n/a Monoclonal Antibody to Checkpoint Kinase 1 (CHEK1) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to Checkpoint Kinase 1 (CHEK1) Polyclonal Antibody Customized Service Offer
Assay Kits n/a CLIA Kit for Checkpoint Kinase 1 (CHEK1) CLIA Kit Customized Service Offer
n/a ELISA Kit for Checkpoint Kinase 1 (CHEK1) ELISA Kit Customized Service Offer
  1. "Conservation of the Chk1 checkpoint pathway in mammals: linkage of DNA damage to Cdk regulation through Cdc25."Science 277:1497-1501(1997) [PubMed] [Europe PMC] [Abstract]
  2. "Atm-dependent interactions of a mammalian chk1 homolog with meiotic chromosomes."Curr. Biol. 7:977-986(1997) [PubMed] [Europe PMC] [Abstract]
  3. "Analysis of the candidate target genes for mutation in microsatellite instability-positive cancers of the colorectum, stomach, and endometrium."Int. J. Oncol. 16:731-737(2000) [PubMed] [Europe PMC] [Abstract]
  4. "Checkpoint kinase 1 (Chk1)-short is a splice variant and endogenous inhibitor of Chk1 that regulates cell cycle and DNA damage checkpoints."Proc. Natl. Acad. Sci. U.S.A. 109:197-202(2012) [PubMed] [Europe PMC] [Abstract]
  5. "Complete sequencing and characterization of 21,243 full-length human cDNAs." Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract]
  6. "Human protein factory for converting the transcriptome into an in vitro-expressed proteome." Nat. Methods 5:1011-1017(2008) [PubMed] [Europe PMC] [Abstract]
  7. "Human chromosome 11 DNA sequence and analysis including novel gene identification." Nature 440:497-500(2006) [PubMed] [Europe PMC] [Abstract]
  8. "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]
  9. "The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites."Genes Dev. 14:289-300(2000) [PubMed] [Europe PMC] [Abstract]
  10. ErratumGenes Dev. 14:750-750(2000)
  11. "Chk1 is an essential kinase that is regulated by Atr and required for the G(2)/M DNA damage checkpoint."Genes Dev. 14:1448-1459(2000) [PubMed] [Europe PMC] [Abstract]
  12. "Activation of mammalian Chk1 during DNA replication arrest: a role for Chk1 in the intra-S phase checkpoint monitoring replication origin firing."J. Cell Biol. 154:913-923(2001) [PubMed] [Europe PMC] [Abstract]
  13. "ATR-mediated checkpoint pathways regulate phosphorylation and activation of human Chk1."Mol. Cell. Biol. 21:4129-4139(2001) [PubMed] [Europe PMC] [Abstract]
  14. "Determination of substrate motifs for human Chk1 and hCds1/Chk2 by the oriented peptide library approach."J. Biol. Chem. 277:16102-16115(2002) [PubMed] [Europe PMC] [Abstract]
  15. ErratumJ. Biol. Chem. 277:35776-35777(2002)
  16. "An ATR- and Chk1-dependent S checkpoint inhibits replicon initiation following UVC-induced DNA damage."Mol. Cell. Biol. 22:8552-8561(2002) [PubMed] [Europe PMC] [Abstract]
  17. "BRCA1 regulates the G2/M checkpoint by activating Chk1 kinase upon DNA damage."Nat. Genet. 30:285-289(2002) [PubMed] [Europe PMC] [Abstract]
  18. "Disruption of the checkpoint kinase 1/cell division cycle 25A pathway abrogates ionizing radiation-induced S and G2 checkpoints."Proc. Natl. Acad. Sci. U.S.A. 99:14795-14800(2002) [PubMed] [Europe PMC] [Abstract]
  19. "Chk1 regulates the S phase checkpoint by coupling the physiological turnover and ionizing radiation-induced accelerated proteolysis of Cdc25A."Cancer Cell 3:247-258(2003) [PubMed] [Europe PMC] [Abstract]
  20. "Human tousled like kinases are targeted by an ATM- and Chk1-dependent DNA damage checkpoint."EMBO J. 22:1676-1687(2003) [PubMed] [Europe PMC] [Abstract]
  21. "SCFbeta-TRCP links Chk1 signaling to degradation of the Cdc25A protein phosphatase."Genes Dev. 17:3062-3074(2003) [PubMed] [Europe PMC] [Abstract]
  22. "Ataxia-telangiectasia-mutated (ATM) and NBS1-dependent phosphorylation of Chk1 on ser-317 in response to ionizing radiation."J. Biol. Chem. 278:14806-14811(2003) [PubMed] [Europe PMC] [Abstract]
  23. "Chk1 mediates S and G2 arrests through Cdc25A degradation in response to DNA-damaging agents."J. Biol. Chem. 278:21767-21773(2003) [PubMed] [Europe PMC] [Abstract]
  24. "Regulation of Chk1 includes chromatin association and 14-3-3 binding following phosphorylation on ser-345."J. Biol. Chem. 278:25207-25217(2003) [PubMed] [Europe PMC] [Abstract]
  25. "Phosphorylation at serine 75 is required for UV-mediated degradation of human Cdc25A phosphatase at the S-phase checkpoint."J. Biol. Chem. 278:29824-29829(2003) [PubMed] [Europe PMC] [Abstract]
  26. "Human claspin is required for replication checkpoint control."J. Biol. Chem. 278:30057-30062(2003) [PubMed] [Europe PMC] [Abstract]
  27. "Chk1 kinase negatively regulates mitotic function of Cdc25A phosphatase through 14-3-3 binding."Mol. Cell. Biol. 23:7488-7497(2003) [PubMed] [Europe PMC] [Abstract]
  28. "Suppression of tousled-like kinase activity after DNA damage or replication block requires ATM, NBS1 and Chk1."Oncogene 22:5927-5937(2003) [PubMed] [Europe PMC] [Abstract]
  29. "MSH2 and ATR form a signaling module and regulate two branches of the damage response to DNA methylation."Proc. Natl. Acad. Sci. U.S.A. 100:15387-15392(2003) [PubMed] [Europe PMC] [Abstract]
  30. "The DNA crosslink-induced S-phase checkpoint depends on ATR-CHK1 and ATR-NBS1-FANCD2 pathways."EMBO J. 23:1178-1187(2004) [PubMed] [Europe PMC] [Abstract]
  31. "Differential mode of regulation of the checkpoint kinases CHK1 and CHK2 by their regulatory domains."J. Biol. Chem. 279:8808-8819(2004) [PubMed] [Europe PMC] [Abstract]
  32. "Centrosome-associated Chk1 prevents premature activation of cyclin-B-Cdk1 kinase."Nat. Cell Biol. 6:884-891(2004) [PubMed] [Europe PMC] [Abstract]
  33. "DNA-dependent phosphorylation of Chk1 and claspin in a human cell-free system."Biochem. J. 388:705-712(2005) [PubMed] [Europe PMC] [Abstract]
  34. "Lack of PTEN sequesters CHK1 and initiates genetic instability."Cancer Cell 7:193-204(2005) [PubMed] [Europe PMC] [Abstract]
  35. "PPM1D dephosphorylates Chk1 and p53 and abrogates cell cycle checkpoints."Genes Dev. 19:1162-1174(2005) [PubMed] [Europe PMC] [Abstract]
  36. "p53 C-terminal phosphorylation by CHK1 and CHK2 participates in the regulation of DNA-damage-induced C-terminal acetylation."Mol. Biol. Cell 16:1684-1695(2005) [PubMed] [Europe PMC] [Abstract]
  37. "Coupling of human circadian and cell cycles by the timeless protein."Mol. Cell. Biol. 25:3109-3116(2005) [PubMed] [Europe PMC] [Abstract]
  38. "The cell-cycle checkpoint kinase Chk1 is required for mammalian homologous recombination repair."Nat. Cell Biol. 7:195-201(2005) [PubMed] [Europe PMC] [Abstract]
  39. "DNA damage-induced mitotic catastrophe is mediated by the Chk1-dependent mitotic exit DNA damage checkpoint."Proc. Natl. Acad. Sci. U.S.A. 102:1065-1070(2005) [PubMed] [Europe PMC] [Abstract]
  40. "14-3-3gamma binds to MDMX that is phosphorylated by UV-activated Chk1, resulting in p53 activation."EMBO J. 25:1207-1218(2006) [PubMed] [Europe PMC] [Abstract]
  41. "Repeated phosphopeptide motifs in human Claspin are phosphorylated by Chk1 and mediate Claspin function."J. Biol. Chem. 281:33276-33282(2006) [PubMed] [Europe PMC] [Abstract]
  42. "Phosphorylation of pRB at Ser612 by Chk1/2 leads to a complex between pRB and E2F-1 after DNA damage."EMBO J. 26:2083-2093(2007) [PubMed] [Europe PMC] [Abstract]
  43. "Chk1-mediated phosphorylation of FANCE is required for the Fanconi anemia/BRCA pathway."Mol. Cell. Biol. 27:3098-3108(2007) [PubMed] [Europe PMC] [Abstract]
  44. "Tryptic digestion of ubiquitin standards reveals an improved strategy for identifying ubiquitinated proteins by mass spectrometry."Proteomics 7:868-874(2007) [PubMed] [Europe PMC] [Abstract]
  45. "ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage."Science 316:1160-1166(2007) [PubMed] [Europe PMC] [Abstract]
  46. "Chk1 suppresses a caspase-2 apoptotic response to DNA damage that bypasses p53, Bcl-2, and caspase-3."Cell 133:864-877(2008) [PubMed] [Europe PMC] [Abstract]
  47. "Nek6 is involved in G2/M phase cell cycle arrest through DNA damage-induced phosphorylation."Cell Cycle 7:2705-2709(2008) [PubMed] [Europe PMC] [Abstract]
  48. "Chk1 and Claspin potentiate PCNA ubiquitination."Genes Dev. 22:1147-1152(2008) [PubMed] [Europe PMC] [Abstract]
  49. "Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle."Mol. Cell 31:438-448(2008) [PubMed] [Europe PMC] [Abstract]
  50. "The checkpoint kinases Chk1 and Chk2 regulate the functional associations between hBRCA2 and Rad51 in response to DNA damage."Oncogene 27:3977-3985(2008) [PubMed] [Europe PMC] [Abstract]
  51. "A quantitative atlas of mitotic phosphorylation."Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed] [Europe PMC] [Abstract]
  52. "Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach."Anal. Chem. 81:4493-4501(2009) [PubMed] [Europe PMC] [Abstract]
  53. "The F box protein Fbx6 regulates Chk1 stability and cellular sensitivity to replication stress."Mol. Cell 35:442-453(2009) [PubMed] [Europe PMC] [Abstract]
  54. "Large-scale proteomics analysis of the human kinome."Mol. Cell. Proteomics 8:1751-1764(2009) [PubMed] [Europe PMC] [Abstract]
  55. "NEK11 regulates CDC25A degradation and the IR-induced G2/M checkpoint."Nat. Cell Biol. 11:1247-1253(2009) [PubMed] [Europe PMC] [Abstract]
  56. "Human FEM1B is required for Rad9 recruitment and CHK1 activation in response to replication stress."Oncogene 28:1971-1981(2009) [PubMed] [Europe PMC] [Abstract]
  57. "Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions."Sci. Signal. 2:RA46-RA46(2009) [PubMed] [Europe PMC] [Abstract]
  58. "NEK11: linking CHK1 and CDC25A in DNA damage checkpoint signaling."Cell Cycle 9:450-455(2010) [PubMed] [Europe PMC] [Abstract]
  59. "Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis."Sci. Signal. 3:RA3-RA3(2010) [PubMed] [Europe PMC] [Abstract]
  60. "Initial characterization of the human central proteome."BMC Syst. Biol. 5:17-17(2011) [PubMed] [Europe PMC] [Abstract]
  61. "System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation."Sci. Signal. 4:RS3-RS3(2011) [PubMed] [Europe PMC] [Abstract]
  62. "The 1.7 A crystal structure of human cell cycle checkpoint kinase Chk1: implications for Chk1 regulation."Cell 100:681-692(2000) [PubMed] [Europe PMC] [Abstract]
  63. "Structural basis for Chk1 inhibition by UCN-01."J. Biol. Chem. 277:46609-46615(2002) [PubMed] [Europe PMC] [Abstract]
  64. "Structure-based design of novel Chk1 inhibitors: insights into hydrogen bonding and protein-ligand affinity."J. Med. Chem. 48:4332-4345(2005) [PubMed] [Europe PMC] [Abstract]
  65. "Patterns of somatic mutation in human cancer genomes." Nature 446:153-158(2007) [PubMed] [Europe PMC] [Abstract]